A systematic review of the pathophysiology of 5-fluorouracil-induced cardiotoxicity

od Polk, Anne, Vistisen, Kirsten, Vaage-Nilsen, Merete, Nielsen, Dorte L
Wydane 2014

Review of hormone-based treatments in postmenopausal patients with advanced breast cancer focusing on aromatase inhibitors and fulvestrant

od Kümler, Iben, Knoop, Ann S, Jessing, Christina A R, Ejlertsen, Bent, Nielsen, Dorte L
Wydane w ESMO Open (2016)

Performance of seven criteria to assess CA125 increments among ovarian cancer patients monitored during first-line chemotherapy and the post-therapy follow-up period

od Abu Hassan, Suher O, Nielsen, Dorte L, Tuxen, Malgorzata K, Petersen, Per H, Sölétormos, György
Wydane w Future Sci OA (2017)

Gene aberrations of RRM1 and RRM2B and outcome of advanced breast cancer after treatment with docetaxel with or without gemcitabine

od Jørgensen, Charlotte LT, Ejlertsen, Bent, Bjerre, Karsten D, Balslev, Eva, Nielsen, Dorte L, Nielsen, Kirsten V
Wydane 2013

TIMP-1 and responsiveness to gemcitabine in advanced breast cancer; results from a randomized phase III trial from the Danish breast cancer cooperative group

od Jørgensen, Charlotte Levin Tykjær, Bjerre, Christina, Ejlertsen, Bent, Bjerre, Karsten D, Balslev, Eva, Bartels, Annette, Brünner, Nils, Nielsen, Dorte L
Wydane 2014

miR-345 in Metastatic Colorectal Cancer: A Non-Invasive Biomarker for Clinical Outcome in Non-KRAS Mutant Patients Treated with 3(rd) Line Cetuximab and Irinotecan

od Schou, Jakob V., Rossi, Simona, Jensen, Benny V., Nielsen, Dorte L., Pfeiffer, Per, Høgdall, Estrid, Yilmaz, Mette, Tejpar, Sabine, Delorenzi, Mauro, Kruhøffer, Mogens, Johansen, Julia S.
Wydane 2014

Myocardial Ischemia Induced by 5‐Fluorouracil: A Prospective Electrocardiographic and Cardiac Biomarker Study

od Dyhl‐Polk, Anne, Schou, Morten, Vistisen, Kirsten K., Sillesen, Anne‐Sophie, Serup‐Hansen, Eva, Faber, Jens, Klausen, Tobias W., Bojesen, Stig E., Vaage‐Nilsen, Merete, Nielsen, Dorte L.
Wydane w Oncologist (2020)